Facebook
Twitter
Telegram
Report an ErrorCastle Biosciences Financial Statements 2011-2024 | CSTL
Annual Financial Statements Castle Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
656 M | 660 M | 1.08 B | 1.27 B | 258 M | - | - | - | - | - | - | - | - |
Shares |
26.8 M | 26.1 M | 25.1 M | 18.9 M | 8.58 M | - | - | - | - | - | - | - | - |
Historical Prices |
24.5 | 25.4 | 42.9 | 67.2 | 34.4 | - | - | - | - | - | - | - | - |
Net Income |
-57.5 M | -67.1 M | -31.3 M | -10.3 M | 5.28 M | -6.37 M | -12.4 M | - | - | - | - | - | - |
Revenue |
220 M | 137 M | 94.1 M | 62.6 M | 51.9 M | 22.8 M | 13.8 M | - | - | - | - | - | - |
Cost of Revenue |
45 M | 32 M | 15.8 M | 9.68 M | 7.31 M | 5.3 M | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 53 M | 44.6 M | 17.5 M | 8.83 M | - | - | - | - | - | - |
Operating Income |
-68 M | -72.9 M | -40.1 M | -6.54 M | 7.33 M | -3.84 M | - | - | - | - | - | - | - |
Interest Expense |
11 K | 17 K | 1 K | 2.63 M | 4.57 M | 2.27 M | - | - | - | - | - | - | - |
EBITDA |
-55.6 M | -62.3 M | -36.7 M | -6.07 M | 7.69 M | -3.51 M | -10.6 M | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 59.5 M | 37.2 M | 21.3 M | 19.7 M | - | - | - | - | - | - |
General and Administrative Expenses |
180 M | 143 M | 86.7 M | 48.1 M | 29.8 M | 16.5 M | 15.3 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Castle Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
27.5 M | 27.4 M | 26.8 M | 26.7 M | 26.6 M | 26.6 M | 26.3 M | 26.1 M | 25.4 M | 25.4 M | 25.3 M | 25.1 M | 24.9 M | 24.8 M | 19.9 M | 17.5 M | 17.4 M | 17.1 M | 12.8 M | 2.15 M | 1.92 M | 1.92 M | 1.91 M | 1.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-2.53 M | - | -6.9 M | -18.8 M | -29.2 M | - | -20.2 M | -1.65 M | -24.6 M | - | -11.8 M | -8.79 M | -4.28 M | -4.89 M | -4.59 M | -1.38 M | 570 K | 2.06 M | 5.85 M | -1.27 M | -1.36 M | 3.87 M | -3.45 M | -3.16 M | -3.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
73 M | - | 61.5 M | 50.1 M | 42 M | - | 37 M | 34.8 M | 26.9 M | - | 23.5 M | 22.8 M | 22.8 M | 17.3 M | 15.2 M | 12.7 M | 17.4 M | 17.6 M | 14.8 M | 10.7 M | 8.72 M | 11.4 M | 3.71 M | 3.98 M | 3.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
13.9 M | - | 11.3 M | 11.1 M | 10.2 M | - | 8.86 M | 7.69 M | 5.94 M | - | 4.5 M | 3.7 M | 3.03 M | - | 2.48 M | 2.15 M | 2.39 M | - | 1.71 M | 1.99 M | 1.6 M | - | 1.35 M | 1.33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | 19.8 M | 14.6 M | 12.7 M | 10.6 M | 15 M | 15.6 M | 13.1 M | 8.75 M | 7.12 M | 10.1 M | 2.36 M | 2.65 M | 2.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.47 M | - | -9.64 M | -21.2 M | -31.5 M | - | -21.5 M | -3.97 M | -24.5 M | - | -11.8 M | -8.81 M | -4.28 M | - | -3.9 M | -645 K | 1.04 M | - | 4.43 M | 608 K | -322 K | - | -2.85 M | -2.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
14 K | - | 2 K | 3 K | 4 K | - | 6 K | 4 K | 3 K | - | - | - | - | - | 706 K | 769 K | 764 K | - | 1.09 M | 1.69 M | 1.02 M | - | 569 K | 525 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-2.13 M | - | -8.74 M | -20.4 M | -28.6 M | - | -20.9 M | -3.44 M | -22.4 M | - | -9.86 M | -7.94 M | -4.05 M | - | -3.59 M | -452 K | 1.13 M | - | 4.52 M | 694 K | -245 K | - | -2.78 M | -2.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | 24.1 M | - | - | - | 14 M | - | 8.64 M | 8.14 M | 7.44 M | - | 5.21 M | 5.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
48.5 M | - | 44.6 M | 44.7 M | 46.8 M | - | 36.6 M | 37.5 M | 30.5 M | - | 22.6 M | 20.8 M | 18.2 M | - | 11.7 M | 10.4 M | 11.1 M | - | 7.12 M | 6.82 M | 6.05 M | - | 3.92 M | 4.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency